Skip to main content
. 2019 Sep 3;20(17):4320. doi: 10.3390/ijms20174320
APC antigen presenting cell
Arg-1 arginine-1
CAA cancer-associated adipocytes
CAF cancer-associated fibroblast
CAR chimeric antigen receptor
cDC conventional DC
CSC cancer stem cell
CTLA-4 cytotoxic T lymphocyte antigen 4
DC dendritic cell
EC endothelial cell
ECM extracellular matrix
EGF epidermal growth factor
EMT epitelial-mesenchymal transition
eTreg effector/activated T reg
EV extracellular vesicle
FGF fibroblast growth factor
GITR glucocorticoid-induced TNFR-related protein
GM-CSF granulocyte-macrophage colony stimulating factor
G-MDSC granulocitic myeloid-derived suppressor cell
HER2 human epidermal growth factor receptor 2
ICI immune checkpoint inhibitor
IDO1 indoleamine 2,3-dioxygenase 1
IGF insulin-like growth factor
IL interleukin
IFN interferon
MDSC myeloid-derived suppressor cell
M-MDSC monocytic-myeloid-derived suppressor cell
MMP matrix metalloproteinase
mo-DC monocytes
mRCC metastatic renal cell carcinoma
MSC mesenchymal stem cells
NK natural killer
NO nitric oxide
NSCLC non-small-cell lung cancer
ORR overall response rate
OS overall survival
PD-1 programmed cell death 1
pDC plasmacytoid DC
PDGF-β platelet-derived growth factor-beta
PD-L1 programmed cell death ligand 1
PGE-2 prostaglandin E-2
PMN pre-metastatic niche
PMN-MDSC polymorphonuclear MDSC
ROS reactive oxygen species
RR response rate
SR survival rate
TAA tumor associated antigens
TAM tumor-associated macrophage
TCR T cell receptor
TGF-β transforming growth factor-beta
TIL tumor-infiltrating lymphocytes
TME tumor microenvironment
TNF-α tumor necrosis factor-alfa
Treg regulatory T cell
VEGFA vascular endothelial growth factor A